Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
10.77
+0.47 (4.56%)
Jan 21, 2025, 4:00 PM EST - Market closed
Benitec Biopharma Employees
Benitec Biopharma had 16 employees as of June 30, 2024. The number of employees decreased by 2 or -11.11% compared to the previous year.
Employees
16
Change (1Y)
-2
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,303,500
Market Cap
250.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
BNTC News
- 2 months ago - Benitec Biopharma to Participate in Upcoming Investor Conferences in December - GlobeNewsWire
- 2 months ago - Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 2 months ago - Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewsWire
- 3 months ago - Benitec Biopharma: OPMD Program Continues To Advance With Catalysts - Seeking Alpha
- 3 months ago - Benitec Biopharma Announces Updated Investor Webcast Information - GlobeNewsWire
- 3 months ago - Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society - GlobeNewsWire
- 4 months ago - Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 4 months ago - Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society - GlobeNewsWire